Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Diagnosis and treatment of co-occurring affective disorders and substance use disorders.

Myrick H, Cluver J, Swavely S, Peters H.

Psychiatr Clin North Am. 2004 Dec;27(4):649-59. Review.

PMID:
15550285
2.

Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.

Brady KT, Verduin ML.

Subst Use Misuse. 2005;40(13-14):2021-41, 2043-8. Review.

PMID:
16282091
3.

Predictors of response to treatment in children and adolescents with mood disorders.

Emslie GJ, Mayes TL, Laptook RS, Batt M.

Psychiatr Clin North Am. 2003 Jun;26(2):435-56. Review.

PMID:
12778842
4.

Mood disorders and substance use disorder: a complex comorbidity.

Quello SB, Brady KT, Sonne SC.

Sci Pract Perspect. 2005 Dec;3(1):13-21. Review.

5.

Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.

Hall W, Degenhardt L, Teesson M.

Addict Behav. 2009 Jun-Jul;34(6-7):526-30. doi: 10.1016/j.addbeh.2009.03.010. Epub 2009 Mar 24.

PMID:
19386422
6.

Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.

Schatzberg AF, Weiss RD, Brady KT, Culpepper L.

CNS Spectr. 2008 Apr;13(4 Suppl 6):3. No abstract available.

PMID:
18408653
7.

Psychiatric comorbidity in forensic psychiatry.

Palijan TZ, Muzinić L, Radeljak S.

Psychiatr Danub. 2009 Sep;21(3):429-36.

8.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
9.

Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.

Merikangas KR, Herrell R, Swendsen J, Rössler W, Ajdacic-Gross V, Angst J.

Arch Gen Psychiatry. 2008 Jan;65(1):47-52. doi: 10.1001/archgenpsychiatry.2007.18.

PMID:
18180428
10.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

11.

Management of comorbid bipolar disorder and substance abuse.

Vornik LA, Brown ES.

J Clin Psychiatry. 2006;67 Suppl 7:24-30. Review.

12.

The impact of co-occurring mood and anxiety disorders among substance-abusing youth.

Lubman DI, Allen NB, Rogers N, Cementon E, Bonomo Y.

J Affect Disord. 2007 Nov;103(1-3):105-12. Epub 2007 Feb 8.

PMID:
17291589
13.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
14.

[Co-occuring mood and substance use disorders].

Adida M, Kaladjian A, Fakra E, Belzeaux R, Azorin JM.

Encephale. 2014 Dec;40 Suppl 3:S8-S13. doi: 10.1016/S0013-7006(14)70124-1. Review. French.

PMID:
25550243
15.

Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.

de Graaf R, Bijl RV, Ten Have M, Beekman AT, Vollebergh WA.

J Affect Disord. 2004 Nov 1;82(3):461-7.

PMID:
15555699
18.

Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.

Bradizza CM, Stasiewicz PR, Paas ND.

Clin Psychol Rev. 2006 Mar;26(2):162-78. Epub 2006 Jan 6. Review.

PMID:
16406196
19.

Magnitude and impact of comorbidity of mental disorders from epidemiologic surveys.

Merikangas KR, Kalaydjian A.

Curr Opin Psychiatry. 2007 Jul;20(4):353-8. Review.

PMID:
17551350
20.

Current status of co-occurring mood and substance use disorders: a new therapeutic target.

Pettinati HM, O'Brien CP, Dundon WD.

Am J Psychiatry. 2013 Jan;170(1):23-30. doi: 10.1176/appi.ajp.2012.12010112. Review.

Supplemental Content

Support Center